Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1H-Benzimidazole-6-carboxylic acid, 1-methyl-(9CI) is an organic compound with the molecular formula C9H8N2O2. It belongs to the benzimidazole family, which is a group of chemical compounds that have a core structure consisting of a benzene ring fused to an imidazole ring. This specific compound features a carboxylic acid group at the 6th position and a methyl group at the 1st position, which may contribute to its unique properties and applications.

53484-18-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 53484-18-7 Structure
  • Basic information

    1. Product Name: 1H-Benzimidazole-6-carboxylicacid,1-methyl-(9CI)
    2. Synonyms: 1H-Benzimidazole-6-carboxylicacid,1-methyl-(9CI);1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID;1-Methyl-1H-1,3-benzodiazole-6-carboxylic acid;3-Methyl-3H-benzo[d]iMidazole-5-carboxylic acid;1-Methyl-6-benziMidazole carboxylic acid;1-Methyl-1H-benzo[d]iMidazole-6-carboxylic acid;1-Methylbenzimidazole-6-carboxylic acid;3-Methyl-3H-benzoimidazole-5-carboxylic acid
    3. CAS NO:53484-18-7
    4. Molecular Formula: C9H8N2O2
    5. Molecular Weight: 176.18
    6. EINECS: N/A
    7. Product Categories: BENZIMIDAZOLE
    8. Mol File: 53484-18-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 411.1 °C at 760 mmHg
    3. Flash Point: 202.4 °C
    4. Appearance: /
    5. Density: 1.35 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: 1H-Benzimidazole-6-carboxylicacid,1-methyl-(9CI)(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1H-Benzimidazole-6-carboxylicacid,1-methyl-(9CI)(53484-18-7)
    11. EPA Substance Registry System: 1H-Benzimidazole-6-carboxylicacid,1-methyl-(9CI)(53484-18-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 53484-18-7(Hazardous Substances Data)

53484-18-7 Usage

Uses

1. Used in Pharmaceutical Synthesis:
1H-Benzimidazole-6-carboxylic acid, 1-methyl-(9CI) is used as a reagent in the synthesis of aminopyridine-derived amides. These amides act as inhibitors of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme that plays a crucial role in cellular metabolism and energy production. Inhibiting NAMPT can have potential therapeutic applications in various diseases, including cancer and inflammatory disorders.
2. Used in Antiprotozoal Drug Development:
1H-Benzimidazole-6-carboxylic acid, 1-methyl-(9CI) is also utilized as a reagent in the synthesis of nitazoxanide-N-methylbenzimidazole hybrids. These hybrids exhibit antiprotozoal activity, making them potentially useful in the development of new drugs to treat protozoan infections, such as those caused by parasites like Giardia, Plasmodium, and Trypanosoma.

Check Digit Verification of cas no

The CAS Registry Mumber 53484-18-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,4,8 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 53484-18:
(7*5)+(6*3)+(5*4)+(4*8)+(3*4)+(2*1)+(1*8)=127
127 % 10 = 7
So 53484-18-7 is a valid CAS Registry Number.

53484-18-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Methyl-1H-benzo[d]imidazole-6-carboxylic acid

1.2 Other means of identification

Product number -
Other names 3-methylbenzimidazole-5-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53484-18-7 SDS

53484-18-7Downstream Products

53484-18-7Relevant articles and documents

Synthesis and antiprotozoal activity of nitazoxanide-N-methylbenzimidazole hybrids

Soria-Arteche, Olivia,Hernandez-Campos, Alicia,Yepez-Mulia, Lilian,Trejo-Soto, Pedro Josue,Hernandez-Luis, Francisco,Gres-Molina, Jorge,Maldonado, Luis A.,Castillo, Rafael

, p. 6838 - 6841 (2014/01/06)

A series of a novel hybrid compounds between nitazoxanide and N-methylbenzimidazole were synthesized starting from the corresponding N-methyl-2-nitroanilines. The new hybrid compounds (1-13) were evaluated in vitro against Giardia intestinalis, Entamoeba

Development of a scalable synthesis of a nonbasic inhibitor of the serine protease tryptase

Dener, Jeffrey M.,O'Bryan, Colin,Yee, Robert,Shelton, Emma J.,Sperandio, David,Mahajan, Tania,Palmer, James T.,Spencer, Jeffrey R.,Tong, Zhiwei

, p. 4591 - 4595 (2007/10/03)

A chromatography-free process for the synthesis of a bis(benzimidazole)difluoromethane inhibitor of the serine protease tryptase is described. This synthesis features the introduction of the gem-difluoro moiety using the electrophilic fluorinating reagent N-fluoro-bis(phenylsulfonimide) as well as the stepwise introduction of both benzimidazole rings. A protocol for the destruction of reactive, process-related substances produced in the synthesis is also presented.

Neutrophil inhibitors to reduce inflammatory response

-

Page/Page column 7, (2010/02/05)

The invention provides novel compounds selected from the group consisting of: The compounds of the present invention are useful for the treatment and prevention of a variety of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment or prevention for the above disorders using theses compounds or the compositions containing them.

4,5,6,7-tetrahydrobenzimidazole derivatives as 5HT3 -antagonists

-

, (2008/06/13)

4,5,6,7-Tetrahydrobenzimidazole derivatives represented by general formula (I) STR1 wherein groups represents the following: R1, R2, R3 : independently represent hydrogen atom, hydroxy group, a halogen atom, a lower alkyl

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53484-18-7